CLASS II ONGOING Drug recall · Reported 8 Jul 2026 · FDA Enforcement Report

Fungal Fusion Eradication Solution, Antifungal & Antimicrobial Kit recalled

Blaine Labs is recalling Fungal Fusion Eradication Solution, Antifungal & Antimicrobial Kit, distributed nationwide in the US. The recall was initiated on 8 Apr 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot BL3572, Exp 04/16/2028
Quantity recalled1,500 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0698-2026
FDA event ID
98731
Recalling firm
Blaine Labs, Santa Fe Springs, CA
Classification
Class II
Status
Ongoing
Recall initiated
8 Apr 2026
FDA classified
16 Jul 2026
Reported
8 Jul 2026
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Potency & Assay

Timeline

8 Apr 2026Recall initiated by company
8 Jul 2026Published in enforcement report+91 days
16 Jul 2026Classified by FDA+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Miconazole Nitrate) Cream, 1x2oz bottle Fungal Fusion Antifungal Solution (25% Undecylenic Acid) and 1x1oz bottle of Fungal Fusion Eradication Antimicrobial Show Spray (isopropyl Alcohol, D-Limonene, Undecylenic Acid). Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670, Manufactured for Doctor's Inc

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Which lots are affected?

Lot BL3572, Exp 04/16/2028

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

7 other products · FDA event 98731

This product is part of a recall event; the main page for the event is Terpenicol Antifungal Solution, (Undecylenic recalled by Blaine Labs.

More recalls from Blaine Labs

All 9